Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Diabetes markedly increases the risk of coronary artery disease and death, but is underrecognised as a cardiovascular risk factor, despite the existence of effective treatments. Because patients with diabetes are at high risk for coronary disease, they have more to gain from prevention. There is evidence from clinical trials that select cardiovascular therapies may work better in diabetes, beyond their expected benefit, and may prevent diabetes itself.

Original publication

DOI

10.7861/clinmedicine.1-6-472

Type

Journal article

Journal

Clin Med (Lond)

Publication Date

11/2001

Volume

1

Pages

472 - 477

Keywords

Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Clinical Trials as Topic, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Humans, Hypoglycemic Agents, Metformin, Risk Factors